Schilling et al. [40], using NZ28, already reported the effectiveness of such an approach for radiosensitization of several tumor cell lines and their data are in full consent with our findings obtained with NZ28 and the other HSF1 inhibitors (quercetin, KNK437, triptolide) in other cell lines. The gene discussed is HSF1; the disease is neoplasm.